Mellergaard Maiken, Skovbakke Sarah Line, Schneider Christine L, Lauridsen Felicia, Andresen Lars, Jensen Helle, Skov Søren
From the Laboratory of Immunology, Section for Experimental Animal Models, Faculty of Health and Medical Sciences, University of Copenhagen, DK-1870 Frederiksberg, Denmark and.
the Department of Biology, Carroll University, Waukesha, Wisconsin 53186.
J Biol Chem. 2014 Jul 18;289(29):20078-91. doi: 10.1074/jbc.M114.573238. Epub 2014 May 28.
NKG2D is an activating receptor expressed on several types of human lymphocytes. NKG2D ligands can be induced upon cell stress and are frequently targeted post-translationally in infected or transformed cells to avoid immune recognition. Virus infection and inflammation alter protein N-glycosylation, and we have previously shown that changes in cellular N-glycosylation are involved in regulation of NKG2D ligand surface expression. The specific mode of regulation through N-glycosylation is, however, unknown. Here we investigated whether direct N-glycosylation of the NKG2D ligand MICA itself is critical for cell surface expression and sought to identify the essential residues. We found that a single N-glycosylation site (Asn(8)) was important for MICA018 surface expression. The frequently expressed MICA allele 008, with an altered transmembrane and intracellular domain, was not affected by mutation of this N-glycosylation site. Mutational analysis revealed that a single amino acid (Thr(24)) in the extracellular domain of MICA018 was essential for the N-glycosylation dependence, whereas the intracellular domain was not involved. The HHV7 immunoevasin, U21, was found to inhibit MICA018 surface expression by affecting N-glycosylation, and the retention was rescued by T24A substitution. Our study reveals N-glycosylation as an allele-specific regulatory mechanism important for regulation of surface expression of MICA018, and we pinpoint the residues essential for this N-glycosylation dependence. In addition, we show that this regulatory mechanism of MICA surface expression is likely targeted during different pathological conditions.
NKG2D是一种在多种人类淋巴细胞上表达的激活受体。NKG2D配体可在细胞应激时被诱导产生,并且在感染或转化的细胞中经常在翻译后被靶向修饰,以避免免疫识别。病毒感染和炎症会改变蛋白质的N-糖基化,我们之前已经表明细胞N-糖基化的变化参与了NKG2D配体表面表达的调控。然而,通过N-糖基化进行调控的具体模式尚不清楚。在这里,我们研究了NKG2D配体MICA自身的直接N-糖基化对于细胞表面表达是否至关重要,并试图确定关键残基。我们发现单个N-糖基化位点(Asn(8))对MICA018的表面表达很重要。经常表达的MICA等位基因008,其跨膜和胞内结构域发生了改变,不受该N-糖基化位点突变的影响。突变分析表明,MICA018胞外结构域中的单个氨基酸(Thr(24))对于N-糖基化依赖性至关重要,而胞内结构域则不参与其中。发现HHV7免疫逃逸蛋白U21通过影响N-糖基化来抑制MICA018的表面表达,并且通过T24A替换可以挽救这种滞留现象。我们的研究揭示了N-糖基化是一种等位基因特异性的调控机制,对MICA018的表面表达调控很重要,并且我们确定了这种N-糖基化依赖性所必需的残基。此外,我们表明MICA表面表达的这种调控机制在不同病理条件下可能会成为靶点。